VISIT CURETODAY.COM   |    SIGN UP FOR THIS AND OTHER CANCER UPDATES

FEATURE

The Jury Is In: Aromatase Inhibitors Are More Effective Than Tamoxifen
By Beverly A. Caley

A Thursday morning session on adjuvant hormonal therapy was probably the strongest session held at San Antonio or ASCO on that topic in years, according to Stephen Jones, MD. “There was a repetitive theme,” he said in an interview with CURE... [MORE]

DAILY BLOGS

	>> Debu Tripathy, MD EDITOR-IN-CHIEF, CURE MAGAZINE The first full day at San Antonio began with discussions about the oldest therapy ever used for breast cancer other than surgery. The demonstration of estrogen’s importance in breast cancer was first noted in 1896 when Sir George Beatson, a Scottish surgeon, noted that removal of the ovaries could make advanced breast cancer regress temporarily... [MORE]
	>> Susan McClure VICE PRESIDENT & PUBLISHER, CURE MAGAZINE As I made my way to the convention center this morning, I heard dialects from every country imaginable. Over the course of the next few days, more than 9,000 people (a new record) from all over the world are expected to converge upon this Texas town, to share critical information that will improve breast cancer treatments worldwide... [MORE]
	>> Joan Venticinque ADVOCATE & GUEST BLOGGER There’s excitement in the air (and a little more warmth) as more attendees descend on the Henry B. Gonzalez Convention Center and the sessions begin. This morning’s presentations concentrated on the use of hormonal therapy as adjuvant therapy for estrogen positive breast cancer... [MORE]

BRIEFS

• Low-Dose Estradiol as Effective as High Dose in Treating Aromatase Inhibitor-Resistant Breast Cancer: A recent discovery that breast cancer cells once fueled by estrogen could be destroyed by the hormone has led to research in which estrogen therapy is introduced after breast cancer cells become resistant to agents, such as aromatase inhibitors, that block estrogen... [MORE]

• The Implications of Micrometastases in Early-Stage Breast Cancer Revealed: Ways to detect cancer cells that have escaped from their original tumor site have become more sensitive as our knowledge and detection methods of circulating cancer cells have improved. One of the commonly used methods is sentinel lymph node dissection... [MORE]

• Komen Awards Give Recognition to Leading Researchers: Nearly 500 people gathered in honor of Susan G. Komen for the Cure’s award program to recognize leading researchers for their work in basic and clinical breast cancer research. This year, Komen honored National Cancer Institute researcher Patricia S. Steeg, PhD, with the Basic Science Award for her work on breast cancer metastases ... [MORE]

ADVOCACY STORY

Becoming an Advocate: The Power of One
In addition to the estimated 8,000 medical professionals and researchers in San Antonio this week, there will be 181 men and women who registered as advocates. These individuals may be part of nonprofit organizations that provide services for patients across the country—from the 35 advocates of the Alamo Breast Cancer Foundation to the women from the Young Survivor Coalition... [MORE]